Topic resource collection
Approved comparison material connected to this topic.
5 resourcesRead both sides
Understanding the DSIP results timeline requires distinguishing between acute pharmacological effects and long-term physiological re-regulation. The table below maps the three primary outcome phases, their measurable biomarkers, …
Polysomnography remains the gold standard for measuring DSIP's neurological effects, but most users lack access to sleep lab equipment. The disconnect between objective data and subjective experience creates confusion when evalua…
DSIP Hypothalamic delta wave modulation 18–31% increase in Stage 3 NREM sleep duration; 8–14 minute reduction in sleep onset latency Minimal to moderate. Subjective improvements often lag 2–4 weeks behind objective changes Intran…
Sleep Latency 22–28 minutes 12–16 minutes −8 to −12 minutes Peptides (1988) intranasal study, n=34 subjects Slow-Wave Sleep % 16–18% of TST 21–26% of TST +5 to +8% Sleep Medicine Reviews meta-analysis REM Latency 85–95 minutes 70…
DSIP (Delta Sleep-Inducing Peptide) GABA-A modulation, HPA axis suppression, delta-wave sleep enhancement Reduced sleep onset latency (10–15 min), 8–12% cortisol reduction, improved HRV 0.5–2mcg/kg nightly, subcutaneous Sleep arc…